210 related articles for article (PubMed ID: 12003419)
21. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Lara LF; Cisneros G; Gurney M; Van Ness M; Jarjoura D; Moauro B; Polen A; Rutecki G; Whittier F
Arch Intern Med; 2003 Sep; 163(17):2079-84. PubMed ID: 14504122
[TBL] [Abstract][Full Text] [Related]
22. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
[TBL] [Abstract][Full Text] [Related]
23. Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
Gisbert JP; Gisbert JL; Marcos S; Pajares JM
Dig Liver Dis; 2004 Jan; 36(1):7-12. PubMed ID: 14971810
[TBL] [Abstract][Full Text] [Related]
24. Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection.
de Boer SY; v d Meeberg PC; Siem H; de Boer WA
Neth J Med; 2003 Jun; 61(6):218-22. PubMed ID: 12956102
[TBL] [Abstract][Full Text] [Related]
25. Twice-a-day quadruple therapy for eradication of Helicobacter pylori in the elderly.
Dore MP; Maragkoudakis E; Pironti A; Tadeu V; Tedde R; Realdi G; Delitala G
Helicobacter; 2006 Feb; 11(1):52-5. PubMed ID: 16423090
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial.
Kuo CH; Hsu PI; Kuo FC; Wang SS; Hu HM; Liu CJ; Chuah SK; Chen YH; Hsieh MC; Wu DC; Tseng HH
J Antimicrob Chemother; 2013 Jan; 68(1):222-8. PubMed ID: 22984204
[TBL] [Abstract][Full Text] [Related]
27. Azithromycin for the cure of Helicobacter pylori infection.
Di Mario F; Dal Bó N; Grassi SA; Rugge M; Cassaro M; Donisi PM; Vianello F; Kusstatscher S; Salandin S; Grasso GA; Ferrana M; Battaglia G
Am J Gastroenterol; 1996 Feb; 91(2):264-7. PubMed ID: 8607490
[TBL] [Abstract][Full Text] [Related]
28. Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori.
Graham DY; Opekun AR; Belson G; El-Zimaity HM; Carlson MR
Aliment Pharmacol Ther; 2005 Jan; 21(2):165-8. PubMed ID: 15679766
[TBL] [Abstract][Full Text] [Related]
29. Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days.
Dore MP; Farina V; Cuccu M; Mameli L; Massarelli G; Graham DY
Helicobacter; 2011 Aug; 16(4):295-300. PubMed ID: 21762269
[TBL] [Abstract][Full Text] [Related]
30. [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia].
Araujo Castillo R; Pinto Valdivia JL; Ramírez D; Cok García J; Bussalleu Rivera A
Rev Gastroenterol Peru; 2005; 25(1):23-41. PubMed ID: 15818420
[TBL] [Abstract][Full Text] [Related]
31. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H
Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317
[TBL] [Abstract][Full Text] [Related]
32. Eradication of helicobacter pylori among patients from a primary care practice.
Gomollón F; Gimeno L; Valdepérez J; Yus C; Marzo J; Pérez-Caballero MC
J Fam Pract; 1996 Dec; 43(6):551-5. PubMed ID: 8969702
[TBL] [Abstract][Full Text] [Related]
33. A 3-day anti-Helicobacter pylori therapy is a good alternative for bleeding peptic ulcer patients with Helicobacter pylori infection.
Hsieh YH; Lin HJ; Tseng GY; Perng CL; Chang FY; Lee SD
Hepatogastroenterology; 2001; 48(40):1078-81. PubMed ID: 11490804
[TBL] [Abstract][Full Text] [Related]
34. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
Gisbert JP; Fuentes J; Carpio D; Tito L; Guardiola J; Tomas A; Olivares D; Calvet X
Aliment Pharmacol Ther; 2005 May; 21(10):1249-53. PubMed ID: 15882246
[TBL] [Abstract][Full Text] [Related]
35. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
[TBL] [Abstract][Full Text] [Related]
36. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
37. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
[TBL] [Abstract][Full Text] [Related]
39. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
[TBL] [Abstract][Full Text] [Related]
40. Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with a high frequency of metronidazole resistance.
Lerang F; Moum B; Ragnhildstveit E; Sandvei PK; Tolås P; Whist JE; Henriksen M; Haug JB; Berge T
Am J Gastroenterol; 1998 Feb; 93(2):212-6. PubMed ID: 9468244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
